LEarning biOchemical Prostate cAncer Recurrence from histopathology sliDes challenge (LEOPARD) Dataset

"This dataset contains the all data for the LEarning biOchemical Prostate cAncer Recurrence from histopathology sliDes challenge or LEOPARD.Prostate cancer, impacting 1.4 million men annually, is a prevalent malignancy (H. Sung et al., 2021). A substantial number of these individuals undergo prostatectomy as the primary curative treatment. The efficacy of this surgery is assessed, in part, by monitoring the concentration of prostate-specific antigen (PSA) in the bloodstream. While the role of PSA in prostate cancer screening is debatable (W. F. Clark et al., 2018; E. A. M. Heijnsdijk et al., 2018), it serves as a valuable biomarker for postprostatectomy follow-up in patients. Following successful surgery, PSA concentration is typically undetectable (<0.1 ng/mL) within 4-6 weeks (S. S. Goonewardene et al., 2014). However, approximately 30% of patie...本数据集包含了“基于组织病理切片学习前列腺癌生化复发”挑战赛（英文缩写LEOPARD）的全部数据。前列腺癌是一种高发恶性肿瘤，每年影响全球140万男性（H. Sung等人，2021）。此类患者中，有相当比例会接受前列腺切除术作为主要治愈性治疗手段。该手术的疗效可部分通过监测患者血液中的前列腺特异性抗原（prostate-specific antigen, PSA）浓度进行评估。尽管PSA在前列腺癌筛查中的作用尚存争议（W. F. Clark等人，2018；E. A. M. Heijnsdijk等人，2018），但其可作为前列腺切除术后患者随访的重要生物标志物。手术成功后，患者血液中的PSA浓度通常会在4-6周内降至检测不出的水平（<0.1 ng/mL）（S. S. Goonewardene等人，2014）。然而，约有30%的患者……